Gvoke HypoPen (glucagon injection)

Gvoke HypoPen (glucagon injection)

Xeris Pharmaceuticals, Inc.

GVOKE HypoPen is a prescription, subcutaneous (under the skin) glucagon injection used to treat severe hypoglycemia (severe low blood glucose) in children and adults with diabetes ages 2 years and above. The product comes in a premixed, ready to use pen and is administered in a 2-step process with no visible needle. Gvoke should be stored at room temperature (68–77 degrees F) and is stable for 30 months (1 mg/0.2 mL dose) or 2 years (0.5 mg/0.1mL dose) from the date of manufacture. It is available in a 1- or 2-pack.


Features

  • Type: Glucagon Injection